Al Nahdi Medical Company SCJSC
SAU:4164
Cash Flow Statement
Cash Flow Statement
Al Nahdi Medical Company SCJSC
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||
| Net Income |
1 342
|
885
|
857
|
898
|
944
|
950
|
938
|
953
|
942
|
900
|
944
|
924
|
908
|
845
|
835
|
845
|
823
|
830
|
|
| Depreciation & Amortization |
790
|
541
|
572
|
579
|
579
|
591
|
597
|
609
|
613
|
609
|
618
|
623
|
649
|
671
|
703
|
732
|
752
|
779
|
|
| Other Non-Cash Items |
257
|
131
|
74
|
105
|
172
|
192
|
222
|
223
|
156
|
113
|
43
|
82
|
145
|
195
|
148
|
180
|
164
|
162
|
|
| Cash Taxes Paid |
77
|
44
|
46
|
41
|
34
|
36
|
40
|
40
|
54
|
54
|
46
|
46
|
44
|
49
|
49
|
49
|
46
|
41
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
79
|
0
|
0
|
0
|
83
|
0
|
0
|
0
|
116
|
36
|
73
|
111
|
|
| Change in Working Capital |
(127)
|
64
|
(169)
|
(142)
|
(92)
|
(162)
|
(89)
|
(64)
|
(341)
|
26
|
(290)
|
(411)
|
(363)
|
(364)
|
(195)
|
(96)
|
(310)
|
(403)
|
|
| Cash from Operating Activities |
2 261
N/A
|
1 620
-28%
|
1 334
-18%
|
1 439
+8%
|
1 603
+11%
|
1 572
-2%
|
1 668
+6%
|
1 721
+3%
|
1 371
-20%
|
1 647
+20%
|
1 316
-20%
|
1 218
-7%
|
1 339
+10%
|
1 348
+1%
|
1 491
+11%
|
1 661
+11%
|
1 429
-14%
|
1 368
-4%
|
|
| Investing Cash Flow | |||||||||||||||||||
| Capital Expenditures |
(470)
|
(292)
|
(306)
|
(274)
|
(278)
|
(277)
|
(275)
|
(286)
|
(305)
|
(332)
|
(385)
|
(410)
|
(425)
|
(396)
|
(384)
|
(387)
|
(387)
|
(435)
|
|
| Other Items |
(383)
|
16
|
7
|
807
|
607
|
4
|
0
|
0
|
0
|
0
|
53
|
1
|
2
|
2
|
56
|
68
|
(209)
|
106
|
|
| Cash from Investing Activities |
(853)
N/A
|
(275)
+68%
|
(299)
-9%
|
533
N/A
|
329
-38%
|
(272)
N/A
|
(275)
-1%
|
(286)
-4%
|
(304)
-7%
|
(332)
-9%
|
(332)
+0%
|
(409)
-24%
|
(424)
-3%
|
(394)
+7%
|
(328)
+17%
|
(319)
+3%
|
(595)
-86%
|
(330)
+45%
|
|
| Financing Cash Flow | |||||||||||||||||||
| Net Issuance of Debt |
(462)
|
(340)
|
(382)
|
(464)
|
(494)
|
(485)
|
(417)
|
(406)
|
(452)
|
(446)
|
(436)
|
(450)
|
(357)
|
(407)
|
(402)
|
(409)
|
(441)
|
(422)
|
|
| Cash Paid for Dividends |
0
|
0
|
(1 260)
|
0
|
0
|
0
|
(300)
|
0
|
(690)
|
(1 015)
|
(715)
|
(1 104)
|
(715)
|
(715)
|
(715)
|
(715)
|
(715)
|
(728)
|
|
| Other |
(995)
|
(1 260)
|
0
|
0
|
(800)
|
(500)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
(1 457)
N/A
|
(1 600)
-10%
|
(1 642)
-3%
|
(1 724)
-5%
|
(1 294)
+25%
|
(986)
+24%
|
(717)
+27%
|
(707)
+1%
|
(1 143)
-62%
|
(1 161)
-2%
|
(1 151)
+1%
|
(1 553)
-35%
|
(1 072)
+31%
|
(1 122)
-5%
|
(1 117)
+0%
|
(1 124)
-1%
|
(1 156)
-3%
|
(1 150)
+1%
|
|
| Change in Cash | |||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
0
|
0
|
0
|
|
| Net Change in Cash |
(49)
N/A
|
(255)
-424%
|
(607)
-138%
|
248
N/A
|
638
+158%
|
314
-51%
|
675
+115%
|
729
+8%
|
(76)
N/A
|
155
N/A
|
(167)
N/A
|
(745)
-347%
|
(157)
+79%
|
(169)
-7%
|
47
N/A
|
218
+362%
|
(322)
N/A
|
(111)
+65%
|
|
| Free Cash Flow | |||||||||||||||||||
| Free Cash Flow |
1 792
N/A
|
1 329
-26%
|
1 028
-23%
|
1 164
+13%
|
1 325
+14%
|
1 295
-2%
|
1 393
+8%
|
1 435
+3%
|
1 066
-26%
|
1 315
+23%
|
932
-29%
|
808
-13%
|
913
+13%
|
952
+4%
|
1 107
+16%
|
1 273
+15%
|
1 043
-18%
|
933
-11%
|
|